Advertisement

Breast Surgeon Eric A. Brown, MD, FACS, Joins Staff at Karmanos Cancer Institute


Advertisement
Get Permission

The Barbara Ann Karmanos Cancer Institute recently announced that breast surgeon Eric A. Brown, MD, FACS, has joined its medical team. Board-certified in general surgery and breast ultrasound, Dr. Brown will serve as co-leader of the Breast Cancer Multidisciplinary Team, alongside Michael Simon, MD, MPH.

Eric A. Brown, MD, FACS

Eric A. Brown, MD, FACS

Michael Simon, MD, MPH

Michael Simon, MD, MPH

“I look forward to working closely with Dr. Brown to serve our patients,” said Dr. Simon. “Having Dr. Brown as a co-leader will allow us to expand our surgical outreach to our community sites, enhance research (especially in the area of surgical oncology), and continue to ensure that patients receive outstanding care at every step of their cancer journey.”

New Role

As co-leader of the Breast Cancer Multidisciplinary Team, Dr. Brown will assist administration in developing regional strategies for breast surgical oncology and develop programs to integrate services within the Karmanos Cancer Network. He will work closely with physicians and surgeons throughout McLaren Health Care to ensure the provision of high-quality breast surgical oncology services.

Additionally, Dr. Brown will oversee clinical groups to enhance the quality of patient care delivered by the team while promoting excellence in clinical research. He will work with the administrative team to elevate awareness of breast health initiatives at Karmanos Cancer Institute

Background and Professional Expertise

In addition to his role at ­Karmanos, Dr. Brown is Assistant Professor of Surgery at Oakland University William Beaumont School of Medicine in Detroit. He is the Breast Program Lead for Michigan Healthcare Professionals, where he is involved in organizing a weekly multidisciplinary tumor board, increasing patient access to clinical trials, and improving patient access to care. He has special interests in neoadjuvant therapies, oncologic safety and outcomes of nipple-sparing mastectomy, and universal genetic testing.

Dr. Brown currently serves as Principal Investigator for the National Surgical Adjuvant Breast and Bowel Project Cooperative Group and the Biobank Project for both patients with triple-negative breast cancer and receiving neoadjuvant chemotherapy for breast cancer. He is the Co-Principal Investigator for the Beaumont Cancer National Cancer Institute Clinical Oncology Research ­Program. 

Dr. Brown earned his MD from the University of Health Sciences/The Chicago Medical School (now Rosalind Franklin University of Medicine and Sciences). He completed general surgery residencies at Mt. Carmel Mercy Hospital and St. John Hospital and Medical Center in Detroit. His previous roles have included leadership positions at Beaumont Hospital, Troy, Michigan, as Director of Oncology Services and as Director of the Center for Breast Health.

 


Advertisement

Advertisement



Advertisement